Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

3.2K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.2K
Autoimmune Disorders01:29

Autoimmune Disorders

2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OPTN/SRTR 2020 Annual Data Report: COVID.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

Original Article: Electrophoretic Properties of Platelets from Normal, Thrombotic and ITP Patients by Doppler Electrophoretic Light Scattering Analysis.

Platelets·2010
Same author

Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis.

Journal of thrombosis and haemostasis : JTH·2008
Same author

Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP.

Thrombosis research·2008
Same author

Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.

East African medical journal·2006
Same author

Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation.

Journal of thrombosis and haemostasis : JTH·2005

Related Experiment Video

Updated: May 5, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

26.8K

Danazol therapy for autoimmune hemolytic anemia.

Y S Ahn, W J Harrington, R Mylvaganam

    Annals of Internal Medicine
    |March 1, 1985
    PubMed
    Summary

    Danazol effectively treats warm antibody autoimmune hemolytic anemia, improving hematocrit in most patients. It offers a valuable alternative for long-term management compared to glucocorticoids.

    Area of Science:

    • Hematology
    • Immunology
    • Pharmacology

    Background:

    • Autoimmune hemolytic anemia (AIHA) of the warm antibody type presents a significant clinical challenge.
    • Current treatment often involves glucocorticoids, which may have long-term side effects.

    Observation:

    • This study assessed danazol's efficacy in 15 patients diagnosed with warm antibody AIHA.
    • Danazol was administered at 600-800 mg/day, either as an add-on therapy or combined with prednisone.

    Findings:

    • A hematocrit increase was observed in 12 of 15 patients within 1-3 weeks.
    • Danazol demonstrated effectiveness irrespective of disease severity or prior treatment outcomes.
    • While erythrocyte-bound IgG and C3 levels decreased, only C3 reduction was statistically significant.

    More Related Videos

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
    06:29

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

    Published on: January 29, 2014

    29.8K
    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
    14:18

    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

    Published on: October 13, 2023

    2.2K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
    13:08

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

    Published on: September 9, 2011

    26.8K
    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
    06:29

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

    Published on: January 29, 2014

    29.8K
    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
    14:18

    Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

    Published on: October 13, 2023

    2.2K

    Implications:

    • Danazol shows promise as a valuable therapeutic option for warm antibody AIHA.
    • It may be a more suitable agent than glucocorticoids for sustained, long-term management of AIHA.
    • Further research is warranted to explore danazol's role in AIHA treatment protocols.